Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Deucravacitinib's trials
COMBo
Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
Deucravacitinib
Ongoing
Not yet recruiting
Phase 4
Open NCT07280702 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
